Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNACK: Abiraterone Bioavailability with Food in Prostate Cancer
NCT02883166Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2016
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of abiraterone in prostate cancer (PCa) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Dose finding based on bioequivalence at 1.5 years. Started Aug 2016; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02883166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02883166.